Solazyme Announces Series D Financing Round of More Than $50 Million

August 9, 2010

For Immediate Release

All Major Existing Investors, including Strategic Investors Chevron and San-Ei Gen, Participate

SOUTH SAN FRANCISCO, California (August 9, 2010) — Solazyme, Inc., a renewable oil production company and leader in algal biotechnology, announced that it has raised $52 million in its Series D financing round. Solazyme uses microbial fermentation to produce renewable oil that can be used for clean and scalable fuels, chemicals, nutritional food ingredients and health and wellness products.

Braemar Energy Ventures and new investor Morgan Stanley are leading the round with all major existing investors from previous rounds participating, including Lightspeed Venture Partners, The Roda Group, Harris and Harris Group and VantagePoint Venture Partners. Existing strategic investors Chevron Technology Ventures, a division of Chevron USA, and San-Ei Gen, a major Japanese manufacturer and distributor of food ingredients, also participated.

"Our technology and commercialization plans are progressing rapidly. We are executing against multiple partnerships with global industry leaders and the U.S. Department of Defense on a rapid path to commercialization,” said Jonathan Wolfson, CEO of Solazyme. “The strong support from our current investors in the Series D is indicative of our ability to exceed milestones, including the production of renewable oil for multiple applications at large scale.”

About Solazyme

Solazyme, Inc. is a renewable oil company and a leader in industrial biotechnology. Founded in 2003 and headquartered in South San Francisco, Solazyme’s proprietary technology transforms a range of low-cost plant-based sugars into high-value oils. Our renewable products can replace or enhance oils derived from the world’s three existing sources—petroleum, plant and animal fats. We tailor the composition of our oils to address specific customer requirements, offering superior performance characteristics at a competitive cost to conventional oils. Solazyme's oils and fuels provide compelling solutions to increasingly complex issues of fuel scarcity, energy security and environmental impact while fitting into the pre-existing multi-trillion dollar fuel infrastructure. Solazyme's investors, among others, include Braemar Energy Ventures, Harris & Harris Group, Lightspeed Venture Partners, The Roda Group, VantagePoint Venture Partners, and Zygote Ventures. For more information, please visit www.solazyme.com.

For more information

Genet Garamendi

VP, Corporate Communications

(650) 963-5228

press@solazyme.com

About Braemar Energy Ventures

Founded in 2003, Braemar Energy Ventures is a leading venture capital firm focused on investing in transformative energy-tech and related companies contributing to global sustainability and combating climate change. Using sector expertise and experience, Braemar aims to be an engaged partner with its portfolio companies to best help them navigate the path to creating significant global impact. For more information, visit braemarenergy.com.